These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33874861)

  • 1. Regulatory Roles of the Notch Signaling Pathway in Liver Repair and Regeneration: A Novel Therapeutic Target.
    Valizadeh A; Sayadmanesh A; Asemi Z; Alemi F; Mahmoodpoor A; Yousefi B
    Curr Med Chem; 2021; 28(41):8608-8626. PubMed ID: 33874861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch signalling beyond liver development: emerging concepts in liver repair and oncogenesis.
    Morell CM; Fiorotto R; Fabris L; Strazzabosco M
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):447-54. PubMed ID: 23806629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complex role of NOTCH receptors and their ligands in the development of hepatoblastoma, cholangiocarcinoma and hepatocellular carcinoma.
    Gil-García B; Baladrón V
    Biol Cell; 2016 Feb; 108(2):29-40. PubMed ID: 26621221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Notch signaling in cholangiocarcinoma.
    Cigliano A; Wang J; Chen X; Calvisi DF
    Expert Opin Ther Targets; 2017 May; 21(5):471-483. PubMed ID: 28326864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapeutic strategies for targeting liver cancer stem cells.
    Oishi N; Wang XW
    Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Notch signaling as a therapeutic approach for liver cancer.
    Wu G; Wilson G; George J; Qiao L
    Curr Gene Ther; 2015; 15(2):171-81. PubMed ID: 25537772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles of Notch signaling in liver disease.
    Geisler F; Strazzabosco M
    Hepatology; 2015 Jan; 61(1):382-92. PubMed ID: 24930574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch signaling and new therapeutic options in liver disease.
    Morell CM; Strazzabosco M
    J Hepatol; 2014 Apr; 60(4):885-90. PubMed ID: 24308992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis.
    Chen LX; Zou SJ; Li D; Zhou JY; Cheng ZT; Zhao J; Zhu YL; Kuang D; Zhu XH
    World J Gastroenterol; 2020 Dec; 26(48):7664-7678. PubMed ID: 33505143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway.
    Wu F; Zhang FY; Tan GQ; Chen WJ; Huang B; Yan L; Zhang HL; Chen S; Jiao Y; Wang BL
    BMC Cancer; 2021 Jun; 21(1):704. PubMed ID: 34130659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs.
    Giovannini C; Fornari F; Piscaglia F; Gramantieri L
    Cells; 2021 Mar; 10(3):. PubMed ID: 33804511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic role of the Notch pathway in primary liver cancer.
    Lu J; Xia Y; Chen K; Zheng Y; Wang J; Lu W; Yin Q; Wang F; Zhou Y; Guo C
    Oncol Lett; 2016 Jul; 12(1):3-10. PubMed ID: 27347091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of transforming growth factor-β, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours (Review).
    Bogaerts E; Heindryckx F; Vandewynckel YP; Van Grunsven LA; Van Vlierberghe H
    Int J Oncol; 2014 Apr; 44(4):1015-22. PubMed ID: 24504124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The developmental origins of Notch-driven intrahepatic bile duct disorders.
    Martinez Lyons A; Boulter L
    Dis Model Mech; 2021 Sep; 14(9):. PubMed ID: 34549776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silybin-mediated inhibition of Notch signaling exerts antitumor activity in human hepatocellular carcinoma cells.
    Zhang S; Yang Y; Liang Z; Duan W; Yang J; Yan J; Wang N; Feng W; Ding M; Nie Y; Jin Z
    PLoS One; 2013; 8(12):e83699. PubMed ID: 24386256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corilagin suppresses cholangiocarcinoma progression through Notch signaling pathway in vitro and in vivo.
    Gu Y; Xiao L; Ming Y; Zheng Z; Li W
    Int J Oncol; 2016 May; 48(5):1868-76. PubMed ID: 26935808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of the Notch signaling pathway inhibits hepatocellular carcinoma cell invasion by inactivation of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor.
    Zhou L; Wang DS; Li QJ; Sun W; Zhang Y; Dou KF
    Oncol Rep; 2012 Sep; 28(3):874-82. PubMed ID: 22736202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch Signaling Pathway in Pancreatobiliary Tumors.
    Borlak F; Reutzel-Selke A; Schirmeier A; Gogolok J; von Hoerschelmann E; Sauer IM; Pratschke J; Bahra M; Schmuck RB
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33498866
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of protein O-fucosyltransferase 1 accelerates hepatocellular carcinoma progression via the Notch signaling pathway.
    Ma L; Dong P; Liu L; Gao Q; Duan M; Zhang S; Chen S; Xue R; Wang X
    Biochem Biophys Res Commun; 2016 Apr; 473(2):503-10. PubMed ID: 27003260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.